Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 3rd quarter

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Jun 25, 2024 3:00pm

165 Views

Post# 36105568

RE:RE:RE:3rd quarter

Right now IMO one concern is that the "central pathology" analysis finds inconsistencies in how the tissue or data was analyzed previously as part of the results the company has been publishing thus far. Since we don't know exactly why the FDA appears to have added that requirement mid-stream, I think it's a legit concern. Receiving BTD will relieve all those types of ambiguous concerns based on lack of info.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth